My Chemo Diary · Encyclopedia
Making sense of the words of cancer care.
Explore genes and biomarkers, cancer types, medicines, tests and side effects. Connect the information and prepare questions for your next appointment.
Official sources · Source-check datesOfficial sources · Source-check dates · 한국어 / English / Français / 日本語
139 entries
BRCA1 and BRCA2 variants
BRCA1 / BRCA2 · DNA repair · PARP
DNA repair genes relevant to some treatments and inherited cancer risk.
Read the entry Genes & biomarkersKRAS variants
KRAS · G12C / G12D / G12V
The exact variant, such as G12C, matters more than “KRAS positive” alone.
Read the entry Genes & biomarkersNRAS variants
NRAS · RAS pathway
A biomarker may help rule out a treatment as well as select one.
Read the entry Genes & biomarkersEGFR variants
EGFR · exon 19 / L858R / exon 20
In lung cancer, the precise EGFR alteration matters.
Read the entry Genes & biomarkersALK fusions and rearrangements
ALK · EML4-ALK
An ALK fusion joins ALK to another gene.
Read the entry Genes & biomarkersROS1 fusions
ROS1 · fusion / rearrangement
A gene fusion relevant to treatment in some lung cancers.
Read the entry Genes & biomarkersBRAF variants
BRAF · V600E / V600K
The BRAF variant and cancer type influence the treatment combination.
Read the entry Genes & biomarkersHER2 / ERBB2 results
ERBB2 · HER2 · IHC / ISH / mutation
Protein expression, gene amplification and gene variants are different findings.
Read the entry Genes & biomarkersPIK3CA variants
PIK3CA · PI3K pathway
Relevant to treatment selection in some hormone receptor-positive breast cancers.
Read the entry Genes & biomarkersESR1 variants
ESR1 · estrogen receptor
ER-positive pathology and an ESR1 variant are different pieces of information.
Read the entry Genes & biomarkersRET fusions and variants
RET · fusion / mutation · MEN2
Distinguish RET fusions in lung cancer from RET variants in medullary thyroid cancer.
Read the entry Genes & biomarkersMET exon 14 and amplification
MET · exon 14 skipping / amplification
MET exon 14 skipping and MET amplification are distinct findings.
Read the entry Genes & biomarkersNTRK1 / NTRK2 / NTRK3 fusions
NTRK1 / NTRK2 / NTRK3 · TRK fusion
An NTRK fusion can guide treatment beyond the organ where a cancer started.
Read the entry Genes & biomarkersFGFR2 fusions and rearrangements
FGFR2 · fusion / rearrangement
FGFR2 fusions/rearrangements are targets in some bile duct cancers.
Read the entry Genes & biomarkersFGFR3 variants
FGFR3 · urothelial cancer
Relevant to treatment in some advanced urothelial cancers.
Read the entry Genes & biomarkersIDH1 variants
IDH1 · IDH1 ≠ IDH2
IDH1 and IDH2 are different treatment targets despite their similar names.
Read the entry Genes & biomarkersFLT3 variants
FLT3 · ITD / TKD
An AML target where variant type and treatment setting matter.
Read the entry Genes & biomarkersBCR::ABL1 fusion
BCR::ABL1 · Philadelphia chromosome · Ph+
A fusion important for targeted treatment and molecular monitoring in CML and related settings.
Read the entry Genes & biomarkersKIT variants
KIT · CD117 · GIST
KIT protein positivity and a KIT gene variant are different findings.
Read the entry Genes & biomarkersPDGFRA variants
PDGFRA · exon 18 / D842V
In GIST, the exact variant, such as D842V, matters for drug selection.
Read the entry Genes & biomarkersUnderstanding gene and biomarker results
Somatic / germline · pathogenic / VUS · tissue / blood
Read the alteration, sample and clinical meaning together, beyond the gene name.
Read the entry Cancer typesBreast cancer
Breast cancer
Stage and hormone-receptor/HER2 results help guide care.
Read the entry Cancer typesNon-small cell lung cancer
Non-small cell lung cancer
Stage and molecular/PD-L1 results can change treatment options.
Read the entry Cancer typesColorectal cancer
Colorectal cancer
Colon and rectal cancers may follow different treatment sequences.
Read the entry Cancer typesStomach cancer
Stomach cancer
Stage, pathology and biomarkers help guide treatment.
Read the entry Cancer typesLiver cancer
Liver cancer
Primary liver cancer differs from cancer that has spread to the liver.
Read the entry Cancer typesPancreatic cancer
Pancreatic cancer
Resectability and overall health are central to planning.
Read the entry Cancer typesProstate cancer
Prostate cancer
Stage, grade, PSA and effects on daily life matter.
Read the entry Cancer typesThyroid cancer
Thyroid cancer
The role of radioactive iodine differs by cancer type.
Read the entry Cancer typesOvarian cancer
Ovarian cancer
Epithelial ovarian, fallopian tube and primary peritoneal cancers are considered together.
Read the entry Cancer typesCervical cancer
Cervical cancer
Discuss stage and plans concerning pregnancy or fertility.
Read the entry Cancer typesKidney cancer
Kidney cancer
An introduction focused on renal cell carcinoma in adults.
Read the entry Cancer typesNon-Hodgkin lymphoma
Non-Hodgkin lymphoma
Start by identifying the subtype and pace of disease.
Read the entry Cancer typesSmall cell lung cancer
Small cell lung cancer · SCLC
Start by understanding the stage and previous treatment.
Read the entry Cancer typesEsophageal cancer
Esophageal cancer
Treatment planning includes swallowing and nutrition.
Read the entry Cancer typesBladder cancer
Bladder cancer
Intravesical treatment differs from systemic medicines.
Read the entry Cancer typesEndometrial cancer
Endometrial cancer
Distinguish it from cervical cancer when discussing treatment.
Read the entry Cancer typesBile duct cancer
Bile duct cancer
Location, resectability and bile drainage guide care.
Read the entry Cancer typesHead and neck cancer
Head and neck cancer
Care includes swallowing, speech and oral health.
Read the entry Cancer typesMelanoma
Melanoma
Tumor thickness, stage and sometimes BRAF results guide treatment.
Read the entry Cancer typesAcute myeloid leukemia
Acute myeloid leukemia
Subtype and genetic results guide prompt treatment planning.
Read the entry Cancer typesMultiple myeloma
Multiple myeloma
Assess bones, kidneys, anemia and the need for treatment.
Read the entry Cancer typesHodgkin lymphoma
Hodgkin lymphoma
Confirm subtype and stage, distinct from non-Hodgkin lymphoma.
Read the entry Cancer typesOsteosarcoma
Osteosarcoma
Plan biopsy, surgery and chemotherapy together.
Read the entry Cancer typesAcute lymphoblastic leukemia
Acute lymphoblastic leukemia
Distinguish B- and T-cell subtypes and genetic results.
Read the entry Cancer typesChronic lymphocytic leukemia
Chronic lymphocytic leukemia
First assess whether treatment is needed now.
Read the entry Cancer typesChronic myeloid leukemia
Chronic myeloid leukemia
BCR::ABL1 and treatment response guide monitoring.
Read the entry Cancer medicinesCisplatin
Cisplatin
A platinum-based cytotoxic chemotherapy.
Read the entry Cancer medicinesCarboplatin
Carboplatin
A platinum chemotherapy often used in combinations.
Read the entry Cancer medicinesPaclitaxel
Paclitaxel
A taxane chemotherapy that interferes with cell division.
Read the entry Cancer medicinesDocetaxel
Docetaxel
A taxane chemotherapy used across several cancers.
Read the entry Cancer medicinesDoxorubicin
Doxorubicin
An anthracycline cytotoxic chemotherapy.
Read the entry Cancer medicinesFluorouracil (5-FU)
Fluorouracil (5-FU)
An antimetabolite used in gastrointestinal and other cancers.
Read the entry Cancer medicinesCapecitabine
Capecitabine
An oral chemotherapy converted into 5-FU in the body.
Read the entry Cancer medicinesOxaliplatin
Oxaliplatin
A platinum chemotherapy that can cause cold sensitivity.
Read the entry Cancer medicinesIrinotecan
Irinotecan
A chemotherapy with an important risk of severe diarrhea.
Read the entry Cancer medicinesGemcitabine
Gemcitabine
A chemotherapy that interferes with DNA building blocks.
Read the entry Cancer medicinesPembrolizumab
Pembrolizumab
An immune checkpoint inhibitor targeting PD-1.
Read the entry Cancer medicinesNivolumab
Nivolumab
A PD-1 inhibitor that supports anti-cancer immune responses.
Read the entry Cancer medicinesTrastuzumab
Trastuzumab
An antibody therapy targeting HER2.
Read the entry Cancer medicinesOsimertinib
Osimertinib
A targeted medicine for lung cancers with certain EGFR mutations.
Read the entry Cancer medicinesBevacizumab
Bevacizumab
Blocks VEGF, a signal involved in tumor blood-vessel growth.
Read the entry Cancer medicinesTarlatamab
Tarlatamab-dlle · Imdelltra
A bispecific T-cell engager that brings immune cells and cancer cells together.
Read the entry Cancer medicinesEtoposide
Etoposide
A chemotherapy used in combinations for small cell lung cancer and other cancers.
Read the entry Cancer medicinesPemetrexed
Pemetrexed
An antifolate used for selected nonsquamous lung cancers and other settings.
Read the entry Cancer medicinesCyclophosphamide
Cyclophosphamide
An alkylating chemotherapy used in breast cancer, lymphomas and other cancers.
Read the entry Cancer medicinesMethotrexate
Methotrexate
An antifolate with cancer-specific routes and schedules.
Read the entry Cancer medicinesRituximab
Rituximab
A CD20-targeting antibody used in selected B-cell lymphomas.
Read the entry Cancer medicinesAtezolizumab
Atezolizumab
An immune checkpoint inhibitor targeting PD-L1.
Read the entry Cancer medicinesDurvalumab
Durvalumab
An immunotherapy used in selected lung and biliary tract cancers and other settings.
Read the entry Cancer medicinesOlaparib
Olaparib
An oral PARP inhibitor used under specific genetic and treatment conditions.
Read the entry Cancer medicinesImatinib
Imatinib
An oral targeted therapy for selected leukemias and gastrointestinal stromal tumors.
Read the entry Cancer medicinesBortezomib
Bortezomib
A proteasome inhibitor used in multiple myeloma and other settings.
Read the entry Cancer medicinesTamoxifen
Tamoxifen
A breast cancer hormone therapy acting on estrogen receptors.
Read the entry Cancer medicinesLetrozole
Letrozole
An aromatase inhibitor that lowers estrogen production.
Read the entry Cancer medicinesAnastrozole
Anastrozole
A nonsteroidal aromatase inhibitor used in selected breast cancers.
Read the entry Cancer medicinesExemestane
Exemestane
A steroidal aromatase inhibitor that suppresses estrogen production.
Read the entry Cancer medicinesFulvestrant
Fulvestrant
An injectable hormone therapy that degrades estrogen receptors.
Read the entry Cancer medicinesGoserelin
Goserelin
A GnRH agonist that suppresses sex hormone production.
Read the entry Cancer medicinesLeuprolide (leuprorelin)
Leuprolide (leuprorelin)
A GnRH agonist used to suppress androgens in prostate cancer.
Read the entry Cancer medicinesAbiraterone
Abiraterone
A prostate cancer therapy that inhibits androgen synthesis.
Read the entry Cancer medicinesEnzalutamide
Enzalutamide
An oral therapy blocking androgen receptor signaling.
Read the entry Cancer medicinesApalutamide
Apalutamide
An androgen receptor inhibitor used in selected prostate cancers.
Read the entry Cancer medicinesDarolutamide
Darolutamide
A medicine blocking androgen signaling in prostate cancer.
Read the entry Cancer medicinesDegarelix
Degarelix
A GnRH antagonist lowering testosterone in prostate cancer.
Read the entry Cancer medicinesPalbociclib
Palbociclib
A CDK4/6-targeted therapy used with endocrine treatment.
Read the entry Cancer medicinesRibociclib
Ribociclib
A CDK4/6 inhibitor paired with endocrine therapy in selected early or advanced breast cancers.
Read the entry Cancer medicinesAbemaciclib
Abemaciclib
A CDK4/6 inhibitor for selected breast cancers, with diarrhea needing particular attention.
Read the entry Cancer medicinesPertuzumab
Pertuzumab
An antibody used in combination treatment for HER2-positive breast cancer.
Read the entry Cancer medicinesTrastuzumab deruxtecan
Trastuzumab deruxtecan
An antibody-drug conjugate delivering cytotoxic treatment through HER2 targeting.
Read the entry Cancer medicinesAlpelisib
Alpelisib
A targeted therapy for selected PIK3CA-mutated breast cancers.
Read the entry Cancer medicinesAlectinib
Alectinib
An oral targeted therapy for ALK-positive non-small cell lung cancer.
Read the entry Cancer medicinesCetuximab
Cetuximab
An EGFR-targeting antibody for selected colorectal and head and neck cancers.
Read the entry Cancer medicinesLenvatinib
Lenvatinib
An oral targeted medicine inhibiting multiple growth and blood-vessel signals.
Read the entry Cancer medicinesSunitinib
Sunitinib
A multikinase inhibitor for selected kidney cancers, GIST and pancreatic neuroendocrine tumors.
Read the entry Cancer medicinesCytarabine
Cytarabine
An antimetabolite used in acute leukemia combination therapy.
Read the entry Cancer medicinesAzacitidine
Azacitidine
A hematology medicine affecting DNA methylation.
Read the entry Cancer medicinesDecitabine
Decitabine
A hypomethylating medicine inhibiting DNA methylation.
Read the entry Cancer medicinesVenetoclax
Venetoclax
An oral leukemia-targeted medicine inhibiting BCL-2.
Read the entry Cancer medicinesGilteritinib
Gilteritinib
A targeted therapy for selected FLT3-mutated AML.
Read the entry Cancer medicinesDasatinib
Dasatinib
A targeted therapy for Philadelphia chromosome-positive leukemias.
Read the entry Cancer medicinesIbrutinib
Ibrutinib
A BTK inhibitor for selected B-cell blood cancers.
Read the entry Cancer medicinesAcalabrutinib
Acalabrutinib
A BTK-targeted medicine for CLL/SLL and selected mantle cell lymphomas.
Read the entry Cancer medicinesVincristine
Vincristine
A vinca alkaloid used in leukemia and lymphoma combinations.
Read the entry Cancer medicinesBendamustine
Bendamustine
A chemotherapy for selected lymphomas and CLL.
Read the entry Cancer medicinesBrentuximab vedotin
Brentuximab vedotin
A lymphoma ADC delivering a drug through CD30 targeting.
Read the entry Cancer medicinesPolatuzumab vedotin
Polatuzumab vedotin
A CD79b-targeting antibody-drug conjugate for selected B-cell lymphomas.
Read the entry Cancer medicinesBlinatumomab
Blinatumomab
A B-cell ALL immunotherapy linking CD19 and CD3.
Read the entry Cancer medicinesLenalidomide
Lenalidomide
An immunomodulatory medicine for myeloma and selected blood disorders.
Read the entry Cancer medicinesPomalidomide
Pomalidomide
An immunomodulatory medicine for selected previously treated myeloma.
Read the entry Cancer medicinesDaratumumab
Daratumumab
A CD38-targeting antibody for multiple myeloma.
Read the entry Cancer medicinesIsatuximab
Isatuximab
A CD38-targeting antibody used in myeloma combinations.
Read the entry Cancer medicinesCarfilzomib
Carfilzomib
A proteasome inhibitor used in selected relapsed/refractory myeloma.
Read the entry Cancer medicinesIxazomib
Ixazomib
An oral proteasome inhibitor for myeloma.
Read the entry Cancer medicinesMelphalan
Melphalan
An alkylating chemotherapy used in myeloma and selected transplant conditioning.
Read the entry TestsNGS testing
Next-generation sequencing
Tests that examine multiple genetic changes to help inform treatment options.
Read the entry TestsComplete blood count (CBC)
Complete blood count (CBC)
Measures red cells, white cells and platelets.
Read the entry TestsLiver function tests
Liver function tests
Checks liver-related enzymes, bilirubin and other substances.
Read the entry TestsKidney function tests
Kidney function tests
Creatinine and eGFR help assess kidney health.
Read the entry TestsElectrolyte tests
Electrolyte tests
Checks sodium, potassium and other electrolyte levels.
Read the entry TestsCT scan
CT scan
Uses x-rays to create cross-sectional images.
Read the entry TestsMRI scan
MRI scan
Creates images using magnets and radio waves.
Read the entry TestsPET-CT scan
PET-CT scan
Combines metabolic activity and anatomical imaging.
Read the entry TestsBiopsy and pathology report
Biopsy and pathology report
Examines sampled cells or tissues to characterize disease.
Read the entry TestsTumor marker tests
Tumor marker tests
Tests that can help assess treatment and follow-up.
Read the entry TestsEchocardiogram
Echocardiogram
Uses ultrasound to assess heart structure and pumping.
Read the entry Side effectsCytokine release syndrome
Cytokine release syndrome · CRS
An immune reaction that can occur after some immunotherapies.
Read the entry Side effectsNeutropenia and fever
Neutropenia and fever
Fever during cancer treatment needs prompt contact with your team.
Read the entry Side effectsAnemia
Anemia
Low red cells or hemoglobin can cause fatigue and breathlessness.
Read the entry Side effectsLow platelets and bleeding
Low platelets and bleeding
Low platelets can make bruising and bleeding easier.
Read the entry Side effectsNausea and vomiting
Nausea and vomiting
Preventive medicines and early advice can help control symptoms.
Read the entry Side effectsDiarrhea
Diarrhea
Diarrhea during treatment needs assessment for dehydration and other causes.
Read the entry Side effectsConstipation
Constipation
Assess stool hardness, pain and abdominal symptoms, not just frequency.
Read the entry Side effectsOral mucositis
Oral mucositis
Mouth pain can affect eating and drinking.
Read the entry Side effectsPeripheral neuropathy
Peripheral neuropathy
Track numbness, sensation changes and difficulty with everyday tasks.
Read the entry Side effectsCancer-related fatigue
Cancer-related fatigue
Fatigue may not be fully relieved by rest.
Read the entry Side effectsTreatment-related hair loss
Treatment-related hair loss
Hair loss and recovery vary with treatment.
Read the entry Side effectsHand-foot syndrome
Hand-foot syndrome
Redness and pain can affect palms and soles.
Read the entry Side effectsImmune-related adverse events
Immune-related adverse events
Immunotherapy can also trigger inflammation in healthy organs.
Read the entry